|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$70,119.43 |
2.15% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$70,316.40 |
2.15% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$69,686.86 |
2.14% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$69,525.12 |
2.13% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$68,950.88 |
2.11% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$68,928.00 |
2.11% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$68,417.49 |
2.10% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$68,233.26 |
2.09% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$68,072.42 |
2.09% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$68,333.79 |
2.09% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$68,132.97 |
2.09% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$68,249.00 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$67,974.14 |
2.08% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$67,901.79 |
2.08% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$67,816.57 |
2.08% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$68,036.50 |
2.08% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$67,680.06 |
2.07% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$67,421.78 |
2.07% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$67,442.40 |
2.07% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$67,668.72 |
2.07% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$67,468.72 |
2.07% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$67,304.54 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
298 |
$67,103.64 |
2.06% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$67,232.60 |
2.06% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$66,831.22 |
2.05% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$66,834.94 |
2.05% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$66,994.41 |
2.05% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$67,017.65 |
2.05% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$66,714.03 |
2.04% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$66,717.27 |
2.04% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$66,674.89 |
2.04% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$66,305.79 |
2.03% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$66,138.00 |
2.03% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$66,136.20 |
2.03% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$65,772.90 |
2.02% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$65,253.84 |
2.00% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$65,162.40 |
2.00% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$64,878.75 |
1.99% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,868.00 |
1.99% |
| Waters Corporation |
WAT |
941848103 |
147 |
$65,096.01 |
1.99% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$64,701.97 |
1.98% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$64,744.15 |
1.98% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$64,735.79 |
1.98% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$64,387.77 |
1.97% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$64,223.28 |
1.97% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$62,037.50 |
1.90% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$59,510.94 |
1.82% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,092.40 |
1.69% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,526.13 |
1.36% |
| US Dollar |
$USD |
|
24,365 |
$24,365.40 |
0.75% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|